Sanofi India Limited
Sanofi India Limited, a subsidiary of the global healthcare leader Sanofi, is headquartered in Mumbai, India. Established in 1956, the company has made significant strides in the pharmaceutical industry, focusing on areas such as diabetes, cardiovascular health, and vaccines. With a strong presence across major operational regions in India, Sanofi India is committed to improving patient outcomes through innovative healthcare solutions.
The company offers a diverse portfolio of core products, including insulin therapies and specialty medicines, which are distinguished by their quality and efficacy. Sanofi India has achieved notable market recognition, consistently ranking among the top pharmaceutical companies in the country. With a dedication to research and development, Sanofi India continues to advance healthcare, making a meaningful impact on the lives of patients across the nation.
+26 vs industry average
Sanofi India Limited’s score of 64 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Sanofi India Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
Sanofi India Limited's reported carbon emissions
In 2023, Sanofi India Limited reported total emissions of approximately 8,334,400 kg CO2e, comprising 486,630 kg CO2e from Scope 1 and 8,477,670 kg CO2e from Scope 2 emissions. The company has consistently disclosed its emissions data, with a slight increase in Scope 1 emissions from 484,010 kg CO2e in 2022, while Scope 2 emissions decreased from 9,282,790 kg CO2e in the same year. Sanofi India Limited is a current subsidiary of Sanofi, and its emissions data is cascaded from the parent company. However, there are currently no disclosed Scope 3 emissions, indicating a gap in reporting on upstream and downstream emissions categories. Despite the absence of specific reduction targets or initiatives, Sanofi India Limited is part of broader climate commitments through its parent company, which participates in various sustainability initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). These commitments reflect the company's dedication to addressing climate change and reducing its carbon footprint in alignment with industry standards.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Sanofi India Limited’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Sanofi India Limited yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
Inherited from Sanofi
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Sanofi
RE 100
Inherited from Sanofi
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Sanofi India Limited
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project